Clec4A4 Acts as a Negative Immune Checkpoint Regulator to Suppress Antitumor Immunity.

Uto, Tomofumi; Fukaya, Tomohiro; Mitoma, Shuya; Nishikawa, Yotaro; Tominaga, Moe; Choijookhuu, Narantsog; Hishikawa, Yoshitaka; Sato, Katsuaki

Uto, Tomofumi; Fukaya, Tomohiro; Mitoma, Shuya; Nishikawa, Yotaro; Tominaga, Moe; Choijookhuu, Narantsog; Hishikawa, Yoshitaka; Sato, Katsuaki.

Afiliação

Uto T; Division of Immunology, Department of Infectious Diseases, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Fukaya T; Japan Agency for Medical Research and Development (AMED), Tokyo, Japan.
Mitoma S; Division of Immunology, Department of Infectious Diseases, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Nishikawa Y; Japan Agency for Medical Research and Development (AMED), Tokyo, Japan.
Tominaga M; Division of Immunology, Department of Infectious Diseases, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Choijookhuu N; Japan Agency for Medical Research and Development (AMED), Tokyo, Japan.
Hishikawa Y; Division of Immunology, Department of Infectious Diseases, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Sato K; Department of Dermatology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

Cancer Immunol Res ; 11(9): 1266-1279, 2023 Sep 01.

Article em En | MEDLINE | ID: mdl-37432112

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google